EVerZom Team

We are driven by our shared belief in the therapeutic potential of exosomes.

Our mission is to work towards the democratization of exosome-based therapies: to bring affordable and easily accessible therapeutics to patients with unmet medical needs. Founded in Paris in 2019, EVerZom has received several prestigious international awards and recognitions for our technology. At EVerZom, we have successfully overcome the challenge of high-yield, large-scale and cost-effective exosome production and developed a unique proprietary innovation platform.

This breakthrough has opened up many potential clinical applications for exosome-based therapies. Our first naive exosome-based candidates have generated promising preclinical data in digestive healing and organs regeneration and our first program is expected to enter the clinic by 2026.

Additional programs are in our pipeline and our platform offers co-development opportunities in regenerative medicine.

Operational team

Jeanne Volatron

CEO and Co founder

PhD in Physics
6 publications

Nicolas Rousseau

CCO & Co founder

Biomedical Engineer
School CentraleSupelec

Julien Branchu

Head of the R&D

PhD in neuroscience

Camille Simon

R&D Scale up project leader

PhD in biophysics

Thibaut Fourniols

R&D and Production Project Leader

PharmD PhD

Clément Bonamy

R&D Project leader

PhD in biology

Maxence Duchemin

R&D engineer and project leader

PhD in immunology

Shony Lemieux

R&D and Production engineer assistant

Isaure Rous

R&D engineer

Pauline Talbot

R&D engineer

Maider Narzabal

R&D engineer

Elise Madec

PhD Student

Characterization ; functionality ; purity

Christophe Wong

PhD student

Functionality of EVs

Stanislas Loiseau

PhD student

Biogenesis of EVs and shear stress

Bastien Thauvin

PhD student

Bioproduction of EVs